US2023218331A1PendingUtilityA1

Renal nerve denervation via the renal pelvis

Assignee: VERVE MEDICAL INCPriority: Jul 12, 2011Filed: Feb 27, 2023Published: Jul 13, 2023
Est. expiryJul 12, 2031(~5 yrs left)· nominal 20-yr term from priority
A61N 7/022A61B 18/00A61B 18/08A61B 18/1492A61B 18/1815A61B 2018/0016A61B 2018/0022A61B 2018/00267A61B 2018/00291A61B 2018/00434A61B 2018/00511A61B 2018/044A61B 2018/046A61B 2018/143A61B 2018/1475A61B 2018/00404A61M 25/10
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Apparatus, systems, and methods provide access to the renal pelvis of a kidney to treat renal nerves embedded in tissue surrounding the renal pelvis. Access to the renal pelvis may be via the urinary tract or via minimally invasive incisions through the abdomen and kidney tissue. Treatment is effected by exchanging energy, typically delivering heat or extracting heat through a wall of the renal pelvis, or by delivering active substances.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for inhibiting the function of renal nerves in a kidney of a patient suffering from hypertension, said method comprising:
 advancing an effector comprising an array of electrodes through the urinary tract into an interior of the kidney or an upper region of an adjacent ureter;   drawing a vacuum through ports on the effector to collapse the wall of the renal pelvis onto the electrodes   delivering radiofrequency energy to the array of electrodes through the interior wall of the renal pelvis to afferent sensory nerves within the wall of the renal pelvis while the wall is collapsed on the electrodes wherein blood pressure of the patient is reduced.   
     
     
         2 . The method as in  claim 1 , wherein the wall of the renal pelvis is partially collapsed onto the electrodes. 
     
     
         3 . The method as in  claim 1 , wherein the effector is advanced to a location where a proximal-most electrode is advanced past a ureteral os. 
     
     
         4 . A method as in  claim 1 , wherein the vacuum is drawn in a lower portion of the renal pelvis. 
     
     
         5 . A method as in  claim 1 , wherein the vacuum is drawn from a vacuum source and the radiofrequency energy is delivered from a radio frequency power source. 
     
     
         6 . A method as in  claim 5 , wherein the vacuum source and the radio frequency power source are both disposed in an external power supply/controller. 
     
     
         7 . A method as in  claim 1 , wherein a temperature of a tissue bed surrounding the afferent sensory nerves in the wall of the renal pelvis is raised to a temperature in a range from 45° C. to 60° C. 
     
     
         8 . A method as in  claim 7 , further comprising irrigating the expanded electrodes to maintain a temperature of the papillae, the parenchyma, and the pyramids in the kidney below 45° C. 
     
     
         9 . A method as in  claim 1 , further comprising expanding the array of electrodes within the kidney or upper region of an adjacent ureter to engage an interior wall of the renal pelvis. 
     
     
         10 . A method as in  claim 1 , wherein the effector is advanced through the urethra, bladder, and ureter to reach the renal pelvis. 
     
     
         11 . A method as in  claim 1 , wherein the radiofrequency energy is delivered for a time in a range from 1 to 2 minutes.

Join the waitlist — get patent alerts

Track US2023218331A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.